Reclassification of Pregabalin and Gabapentin
As mentioned in the Latest News post of 17th October 2018 – and also featured in the forthcoming issue, issue 71, of Pain Matters – as of 1st April 2019, prescription drugs Pregabalin and Gabapentin are to be reclassified as Class C controlled substances. NHS England has just published updated guidelines for patients and healthcare professionals, to be distributed in March 2019.
Click here for the healthcare professionals’ guidance.
Click here for the patients’ handout.